Literature DB >> 21665309

Metabolism of tumors under treatment: mapping of metabolites with quantitative bioluminescence.

Angela Broggini-Tenzer1, Van Vuong, Martin Pruschy.   

Abstract

BACKGROUND AND
PURPOSE: The metabolic switch to aerobic glycolysis (Warburg effect) and enhanced lactate production is characteristic for aggressive tumor cells and is a co-determining factor for tumor response and treatment outcome. Thus analysis of the metabolic status under treatment is important to understand and improve treatment modalities.
MATERIALS AND METHODS: Metabolite concentrations were determined by the immersion of tumor sections in an ATP, lactate or glucose-depending luciferase-containing buffer system. Integrated light output is detected in a bioluminescent detection system.
RESULTS: Mice carrying tumor xenografts derived from A549 lung cancer cells were treated with the microtubule stabilizing agent patupilone, ionizing radiation or in combination. Lactate levels were significantly reduced and glucose levels drastically increased in comparison to untreated tumors. Interestingly, these changes were only minimal in tumors derived from patupilone-resistant but otherwise isogenic A549EpoB40 cells. ATP levels of all tumors tested did not change under any treatment. When compared with histological endpoints, basal and treatment-dependent changes of lactate levels in the different tumors mainly correlated with the proliferative activity and the tumor growth response to treatment.
CONCLUSIONS: This study shows that the tumor metabolism is responsive to different treatment modalities and could eventually be used as an early surrogate marker for treatment response.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21665309     DOI: 10.1016/j.radonc.2011.05.041

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  5 in total

1.  Glycolysis-related gene induction and ATP reduction during fractionated irradiation. Markers for radiation responsiveness of human tumor xenografts.

Authors:  K Goetze; S S Meyer; A Yaromina; D Zips; M Baumann; W Mueller-Klieser
Journal:  Strahlenther Onkol       Date:  2013-07-06       Impact factor: 3.621

2.  Improved clearance during treatment of HPV-positive head and neck cancer through mTOR inhibition.

Authors:  Joseph D Coppock; Bryant G Wieking; Alfredo A Molinolo; J Silvio Gutkind; W Keith Miskimins; John H Lee
Journal:  Neoplasia       Date:  2013-06       Impact factor: 5.715

3.  Coupling of glucose deprivation with impaired histone H2B monoubiquitination in tumors.

Authors:  Yasuyo Urasaki; Linda Heath; C Wilson Xu
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

4.  Ionizing radiation induces tumor cell lysyl oxidase secretion.

Authors:  Colette J Shen; Ashish Sharma; Dinh-Van Vuong; Janine T Erler; Martin Pruschy; Angela Broggini-Tenzer
Journal:  BMC Cancer       Date:  2014-07-22       Impact factor: 4.430

5.  Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation.

Authors:  Li Gao; Ke-Xin Wang; Yu-Zhi Zhou; Jian-Song Fang; Xue-Mei Qin; Guan-Hua Du
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.